Alcon (SIX/NYSE: ALC) recently announced that it has settled a patent dispute with J&J Surgical Vision.
The $199 million settlement, announced Feb. 12, ends a lawsuit that J&J had filed in June 2020 in U.S. District Court in Delaware. J&J Surgical Vision had claimed that Alcon femtosecond laser-assisted cataract surgery devices, including the company’s LenSx device, infringed on one or more claims in 12 of J&J’s U.S. patents.
The LenSx laser system cataract procedures [Image courtesy of Alcon]